Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1985 2
1986 1
1987 5
1988 2
1989 3
1990 1
1991 2
1992 4
1993 6
1994 2
1995 3
1996 2
1997 6
1998 6
1999 6
2000 6
2001 5
2002 4
2003 3
2004 4
2005 2
2006 7
2007 5
2008 3
2009 1
2011 3
2013 3
2015 1
2016 3
2017 1
2018 2
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.
Veyradier A, Boisseau P, Fressinaud E, Caron C, Ternisien C, Giraud M, Zawadzki C, Trossaert M, Itzhar-Baïkian N, Dreyfus M, d'Oiron R, Borel-Derlon A, Susen S, Bezieau S, Denis CV, Goudemand J; French Reference Center for von Willebrand disease. Veyradier A, et al. Among authors: fressinaud e. Medicine (Baltimore). 2016 Mar;95(11):e3038. doi: 10.1097/MD.0000000000003038. Medicine (Baltimore). 2016. PMID: 26986123 Free PMC article.
Laboratory diagnosis of von Willebrand disease.
Veyradier A, Fressinaud E, Meyer D. Veyradier A, et al. Among authors: fressinaud e. Int J Clin Lab Res. 1998;28(4):201-10. doi: 10.1007/s005990050046. Int J Clin Lab Res. 1998. PMID: 9879492 Review.
von Willebrand factor: structure and function.
Meyer D, Piétu G, Fressinaud E, Girma JP. Meyer D, et al. Among authors: fressinaud e. Mayo Clin Proc. 1991 May;66(5):516-23. doi: 10.1016/s0025-6196(12)62394-5. Mayo Clin Proc. 1991. PMID: 1903172 Review.
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
Poon MC, d'Oiron R, Hann I, Négrier C, de Lumley L, Thomas A, Karafoulidou A, Demers C, Street A, Huth-Kühne A, Petrini P, Fressinaud E, Morfini M, Tengborn L, Marquès-Verdier A, Musso R, Devecioglu O, Houston DS, Lethagen S, Van Geet C, von Depka M, Berger C, Beurrier P, Britton HA, Gerrits W, Guthner C, Kuhle S, Lorenzo JJ, Makris PE, Nohe N, Paugy P, Pautard B, Torchet MF, Trillot N, Vicariot M, Wilde J, Winter M, Chambost H, Ingerslev J, Peters M, Strauss G. Poon MC, et al. Among authors: fressinaud e. Semin Hematol. 2001 Oct;38(4 Suppl 12):21-5. doi: 10.1016/s0037-1963(01)90143-x. Semin Hematol. 2001. PMID: 11735106 Review.
Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A.
Saultier P, Guillaume Y, Demiguel V, Berger C, Borel-Derlon A, Claeyssens S, Harroche A, Oudot C, Rafowicz A, Trossaert M, Wibaut B, Vinciguerra C, Boucekine M, Baumstarck K, Meunier S, Calvez T, Chambost H; FranceCoag PUPs / CoMETH Prophylaxis Study Group; Hemophilia Treatment Centers of Paris-Necker. Saultier P, et al. J Pediatr. 2021 Jul;234:212-219.e3. doi: 10.1016/j.jpeds.2021.02.071. Epub 2021 Mar 4. J Pediatr. 2021. PMID: 33676933 Clinical Trial.
103 results